Cellectar Biosciences (CLRB) Misses Q1 EPS by 133c

Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($1.33).

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Compass Point Starts Gorilla Tech Group/ (GRRR) at Buy